1. Inicio
  2. Publicaciones
  3. Tuberculosis Following Lung Transplantation. A 27-Year Spanish Multicenter Experience. Incidence, Presentation, Prevention and Treatment with Rifampicin.

Tuberculosis Following Lung Transplantation. A 27-Year Spanish Multicenter Experience. Incidence, Presentation, Prevention and Treatment with Rifampicin.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Part-Lopez M.
  • Saez B.
  • Laporta R.
  • Anguera G.
  • Cuesta V.M.
  • De Pablo A.
  • Canyada-Martinez A.J.
  • Caminero J.A.

Grupos

Abstract

Tuberculosis (TB) represents a diagnostic and therapeutic challenge for solid organ transplant recipients, particularly after lung transplant (LT). Our aim was to determine the impact of TB in LT patients in Spain, considering prevalence, clinical presentation, prevention and therapeutic management. In addition, differences in outcome between rifampicin (RIF) versus non-RIF containing regimens were analyzed.

Datos de la publicación

ISSN/ISSNe:
0300-2896, 1579-2129

ARCHIVOS DE BRONCONEUMOLOGIA  ELSEVIER ESPANA SLU

Tipo:
Article
Páginas:
493-498
PubMed:
31771919
Enlace a otro recurso:
www.scopus.com
Factor de Impacto:
0,302 SCImago ℠
Cuartil:
Q3 SCImago ℠

Citas Recibidas en Web of Science: 3

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Infección tuberculosa latente, Latent tuberculosis infection, Lung transplant, Mycobacterium tuberculosis, Trasplante de pulmón, Tuberculosis

Campos de Estudio

Cita

Compartir